FDA recall record

Denver Solutions, LLC DBA Leiters Health dexmedeTOMIDine HCl PF, in 0.9% Sodium Chloride, 20 recall — FDA D-0371-2025

Lack of Assurance of Sterility: Leaking/damaged syringes.

Class IIclassification
D-0371-2025official record ID
Apr 30, 2025report date

Recall record at a glance

Official recordD-0371-2025
CategoryDrug Recalls
ClassificationClass II
FDA record statusOngoing
Recalling firmDenver Solutions, LLC DBA Leiters Health
Report dateApr 30, 2025
Recall initiation dateMar 31, 2025
Quantity23,610 syringes
LocationEnglewood, CO, United States

Official product description

dexmedeTOMIDine HCl PF, in 0.9% Sodium Chloride, 20 mcg (base) per 5mL, (4 mcg (base) per mL), 5mL Single Dose syringe, Rx only, Leiters Health, 13796 Compark Blvd, Englewood, CO 80112, NDC: 71449-131-11.

Why the product was recalled

Lack of Assurance of Sterility: Leaking/damaged syringes.

Distribution information

Nationwide in the U.S.A

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.